It is not FDA-approved for human use
According to DataM Intelligence, the market was valued at US$0.96 billion in 2025 and is projected to reach US$2.08 billion by 2033, expanding at a CAGR of 10% during Bioelectric Medicine Market Widens Beyond Chronic Pain as Wearable Neurostimulat NEW YORK, July 31, 2026 - The global bioelectric medicine market reached US$31.34 billion in 2024 and is projected to reach US$235.55 billion by 2033, growing at a compound annual growth rate of 22.3% between 2025 and 2033, according to DataM Intelligence
Injecting the same spot repeatedly causes lipohypertrophy
Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, serious pancreatitis, severe dehydration, or pregnancy
This article is for educational purposes only and does not constitute medical advice